Major Depressive Disorder Clinical Trial
Official title:
Internet-Based Depression Screening for College Students
Verified date | April 2015 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This study aims to determine whether using telecommunication tools, specifically web pages
containing online screening instruments and real-time video chat, will be an efficient way
to implement Major Depressive Disorder screening among college students. The study also aims
to determine if proactive depression screening and free online consultation with a
psychiatrist will increase the rate of help-seeking among college students with MDD.
Eligible participants will complete a demographics survey and depression screening
assessment online. Those subjects who express suicidality or depressive symptoms will be
offered the opportunity to complete a one-time psychiatric consultation with Skype
video-conferencing.
Status | Completed |
Enrollment | 1900 |
Est. completion date | December 2014 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: - All who consider themselves current undergraduate from Massachusetts colleges are encouraged to participate. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
Country | Name | City | State |
---|---|---|---|
United States | Depression Clinical and Research Program at Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
United States,
Shyu I, Soo JY, Fava M, Kvedar J, Yeung A. Internet Based Depression Screening for College Students. Proceedings of the 163rd Annual Meeting of the American Psychiatric Association (APA). New Orleans, LA, 2010.
Soo JY, Shyu, I, Kvedar J, Fava M, Yeung A. The use of Facebook to advertise depression screening among college students: A feasibility and effectiveness study. Proceedings of the 62nd Annual Meeting of the Institute of Psychiatric Services (IPS). Boston,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 9-item Patient Health Questionnaire | Subjects are given the PHQ-9 at baseline, and a 8-week follow-up survey that includes PHQ-9 and questions inquiring whether subject has begun treatment for MDD and whether they faced obstacles in seeking treatment. | Baseline, Week 8 | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A | |
Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 |